Table 1.
Baseline characteristics.
| Variables | No. of patients (%) |
|---|---|
| Age(year) | |
| <60 | 36 (47.4%) |
| ≥60 | 40 (52.6%) |
| Gender | |
| Male | 41 (53.7%) |
| Female | 35 (46.1%) |
| Tumor stage | |
| T1-T2 | 32 (42.1%) |
| T3-T4 | 44 (57.9%) |
| Lymph node metastasis | |
| No | 51 (67.1%) |
| Yes | 25 (32.9%) |
| Liver invasion | |
| No | 63 (82.9%) |
| Yes | 13 (17.1%) |
| Portal vein invasion | |
| No | 37 (48.7%) |
| Yes | 39 (51.3%) |
| Neural invasion | |
| No | 22 (28.9%) |
| Yes | 54 (71.1%) |
| Bismuth-Coretre type | |
| I-II | 33 (43.4%) |
| III-IV | 43 (56.6%) |
| Tumor differentiation | |
| Moderate/poor | 65 (85.5%) |
| well | 11 (14.5%) |
| Tumor size (cm) | |
| <3 | 50 (64.9%) |
| ≥3 | 26 (33.8%) |
| Total bilirubin (μmol/L) | |
| <34.2 | 13 (17.1%) |
| ≥34.2 | 63 (82.9%) |